Scandinavian ChemoTech AB (publ) (FRA:8V6)
Germany
· Delayed Price · Currency is EUR 0.287
-0.004 (-1.37%)
Last updated: Dec 5, 2025, 8:03 AM CET
Scandinavian ChemoTech AB Income Statement
Financials in millions SEK. Fiscal year is January - December.
Millions SEK. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2019 - 2015 |
|---|---|---|---|---|---|---|---|
Period Ending | Sep '25 Sep 30, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2019 - 2015 |
| Operating Revenue | 11.68 | 6.57 | 2.82 | 0.47 | 2.59 | 1.41 | Upgrade
|
| Revenue | 11.68 | 6.57 | 2.82 | 0.47 | 2.59 | 1.41 | Upgrade
|
| Revenue Growth (YoY) | 132.08% | 132.67% | 496.62% | -81.70% | 82.82% | -69.63% | Upgrade
|
| Cost of Revenue | 2.08 | 1.79 | 1.16 | 0.53 | -0.27 | 0.15 | Upgrade
|
| Gross Profit | 9.59 | 4.78 | 1.66 | -0.06 | 2.86 | 1.27 | Upgrade
|
| Selling, General & Admin | 14.73 | 15.41 | 19.12 | 17.86 | 16.96 | 10.33 | Upgrade
|
| Other Operating Expenses | 0.22 | 0.11 | 0.1 | 0.05 | 0.16 | -0.16 | Upgrade
|
| Operating Expenses | 16.98 | 17.57 | 21.9 | 20.86 | 19.94 | 12.1 | Upgrade
|
| Operating Income | -7.38 | -12.8 | -20.24 | -20.91 | -17.08 | -10.83 | Upgrade
|
| Interest Expense | -1.57 | -1.18 | -1.4 | -1.9 | -0.68 | -0.84 | Upgrade
|
| Interest & Investment Income | 0.26 | 0.26 | 0.55 | 0.06 | 0.01 | - | Upgrade
|
| Pretax Income | -8.7 | -13.72 | -21.09 | -22.75 | -17.74 | -11.66 | Upgrade
|
| Net Income | -8.7 | -13.72 | -21.09 | -22.75 | -17.74 | -11.66 | Upgrade
|
| Net Income to Common | -8.7 | -13.72 | -21.09 | -22.75 | -17.74 | -11.66 | Upgrade
|
| Shares Outstanding (Basic) | 23 | 21 | 13 | 10 | 9 | 5 | Upgrade
|
| Shares Outstanding (Diluted) | 23 | 21 | 13 | 10 | 9 | 5 | Upgrade
|
| Shares Change (YoY) | 26.18% | 53.13% | 35.31% | 15.17% | 75.79% | 51.41% | Upgrade
|
| EPS (Basic) | -0.37 | -0.66 | -1.56 | -2.28 | -2.05 | -2.37 | Upgrade
|
| EPS (Diluted) | -0.37 | -0.66 | -1.56 | -2.28 | -2.05 | -2.37 | Upgrade
|
| Free Cash Flow | -10.66 | -18.23 | -18.23 | -19.49 | -19.24 | -8.52 | Upgrade
|
| Free Cash Flow Per Share | -0.46 | -0.88 | -1.35 | -1.96 | -2.22 | -1.73 | Upgrade
|
| Gross Margin | 82.15% | 72.75% | 58.75% | -11.63% | 110.60% | 89.74% | Upgrade
|
| Operating Margin | -63.22% | -194.88% | -717.12% | -4421.14% | -660.62% | -765.84% | Upgrade
|
| Profit Margin | -74.49% | -208.91% | -747.38% | -4808.88% | -686.38% | -824.89% | Upgrade
|
| Free Cash Flow Margin | -91.27% | -277.58% | -645.85% | -4119.87% | -744.18% | -602.83% | Upgrade
|
| EBITDA | -7.25 | -12.63 | -20.13 | -20.87 | -17.04 | -10.77 | Upgrade
|
| EBITDA Margin | -62.10% | -192.40% | - | - | - | - | Upgrade
|
| D&A For EBITDA | 0.13 | 0.16 | 0.11 | 0.04 | 0.04 | 0.06 | Upgrade
|
| EBIT | -7.38 | -12.8 | -20.24 | -20.91 | -17.08 | -10.83 | Upgrade
|
| EBIT Margin | -63.22% | -194.88% | - | - | - | - | Upgrade
|
| Revenue as Reported | 11.85 | 6.77 | 2.98 | 0.51 | 2.59 | 1.43 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.